Overview

Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease

Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to examine the efficacy of memantine on cognition and behavioural symptoms in outpatients with moderate to severe dementia of the Alzheimer's type.
Phase:
Phase 3
Details
Lead Sponsor:
H. Lundbeck A/S
Treatments:
Memantine